Skip to main content
Home
PRODUCTS
Disease areas
Evidences
SEPSIS
COVID19
ALLERGY
FERRITIN
cSOFA
SCIENTIFIC PUBLICATIONS
About Us
News
Contact
Career
Menu
Select your language
en
fr
de
it
Go
Toggle navigation
Mobile menu
Home
Products
Disease areas
Evidences
SEPSIS
COVID19
ALLERGY
FERRITIN
cSOFA
SCIENTIFIC PUBLICATIONS
About Us
Contact
News
Career
News
Media & press
All
Articles
News
Press Releases
Apply
News
Tuesday, 28 May 2019
Biotech-Unternehmen schwimmen im Geld
Read article
News
Wednesday, 01 May 2019
OTX World - Course Effrénée Contre la Montre
Read article
News
Sunday, 21 April 2019
Startup Guide 2019
Read article
News
Friday, 28 September 2018
La société Abionic veut sauver des vies
Read article
News
Sunday, 01 July 2018
Abionic SA: Revolutionising the World of In Vitro Diagnostics
Read article
News
Friday, 01 June 2018
Abionic - Un Succès Vaudois
Read article
Press Releases
Wednesday, 28 March 2018
Abionic Successfully Raises CHF20 Million in Series C Financing
Read article
Press Releases
Wednesday, 06 December 2017
Abionic Announces Appointment of Leading Diagnostics Industry Experts to Board of Directors
Read article
Press Releases
Friday, 20 October 2017
Abionic Announces FDA Registration for World’s Most Rapid Allergy Test and abioSCOPE Diagnostic Testing Platform
Read article
Press Releases
Wednesday, 13 September 2017
World Sepsis Day 2017 - Abionic to improve early diagnosis of Sepsis and treatment management
Read article
Press Releases
Wednesday, 31 May 2017
World's Fastest Sepsis Test from Abionic Produces Result in Five Minutes when tested in Patients at London and Zurich Hospitals
Read article
Press Releases
Friday, 10 February 2017
Abionic awarded twice in a week: SEF High Potential & Finance Monthly Game Changers Awards
Read article
News
Monday, 30 January 2017
The blood test that detects killer Sepsis in five minutes: Revolutionary treatment could save thousands of lives, and may soon be introduced in the NHS.
Read article
News
Friday, 20 January 2017
Abionic's New POC Sepsis Test On Rapid Move To Market
Read article
Press Releases
Monday, 09 January 2017
Abionic Receives CE Mark for Most Rapid Sepsis and Iron Deficiency Point of Care Diagnostics
Read article